Last reviewed · How we verify
Fluconazole Loading Dose
At a glance
| Generic name | Fluconazole Loading Dose |
|---|---|
| Also known as | Diflucan |
| Sponsor | Daniel Benjamin |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Pyrexia
- Hypokalaemia
- Anaemia
- Hypomagnesaemia
- Diarrhoea
- Pneumonia
- Vomiting
- Abdominal pain
- Constipation
- Hypophosphataemia
- Nausea
- Hypotension
Key clinical trials
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (PHASE3)
- Platform Trial For Cryptococcal Meningitis (PHASE2, PHASE3)
- Study of Biomarker-Based Treatment of Acute Myeloid Leukemia (PHASE1, PHASE2)
- Fluconazole Versus Micafungin in Neonates With Candidiasis (PHASE2, PHASE3)
- A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients (PHASE2)
- Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis (PHASE2)
- A Study to Evaluate Potential Drug Interactions Between ALXN2080 and Itraconazole, Fluconazole & Carbamazepine in Healthy Adults (PHASE1)
- Efficacy of Prophylactic Fluconazole Therapy in Preterm and Very Low Birth Weight Neonates in Preventing Invasive Fungal Infection. (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fluconazole Loading Dose CI brief — competitive landscape report
- Fluconazole Loading Dose updates RSS · CI watch RSS
- Daniel Benjamin portfolio CI